Literature DB >> 23165397

Prostate cancer: 'Galectin signature' reveals gal-1 as key player in angiogenesis.

Sarah Payton.   

Abstract

Entities:  

Year:  2012        PMID： 23165397     DOI： 10.1038/nrurol.2012.216

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease.

Authors:  Diego J Laderach; Lucas D Gentilini; Laura Giribaldi; Victor Cardenas Delgado; Lorena Nugnes; Diego O Croci; Nader Al Nakouzi; Paula Sacca; Gabriel Casas; Osvaldo Mazza; Margaret A Shipp; Elba Vazquez; Anne Chauchereau; Jeffery L Kutok; Scott J Rodig; María T Elola; Daniel Compagno; Gabriel A Rabinovich
Journal:  Cancer Res       Date:  2012-10-29       Impact factor: 12.701
  1 in total
  2 in total

1.  Tissue and plasma levels of galectins in patients with high grade serous ovarian carcinoma as new predictive biomarkers.

Authors:  Marilyne Labrie; Lorenna Oliveira Fernandes De Araujo; Laudine Communal; Anne-Marie Mes-Masson; Yves St-Pierre
Journal:  Sci Rep       Date:  2017-10-16       Impact factor: 4.379

2.  Diagnosis of prostate cancer by desorption electrospray ionization mass spectrometric imaging of small metabolites and lipids.

Authors:  Shibdas Banerjee; Richard N Zare; Robert J Tibshirani; Christian A Kunder; Rosalie Nolley; Richard Fan; James D Brooks; Geoffrey A Sonn
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-14       Impact factor: 11.205
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.